Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Ophthalmology
Published in: BMC Ophthalmology 1/2016

Open Access 01-12-2016 | Research article

Anterior chamber depth and angle-closure glaucoma after central retinal vein occlusion

Authors: Shiu-Chen Wu, Yung-Sung Lee, Wei-Chi Wu, Shirley H. L. Chang

Published in: BMC Ophthalmology | Issue 1/2016

Login to get access

Abstract

Background

The purpose of this study was to report the anterior chamber (AC) depth and the attack of angle-closure glaucoma (ACG) in eyes with the recent onset of central retinal vein occlusion (CRVO).

Methods

This retrospective case series included 24 patients with recent onset of CRVO (within one month of attack) from July 2001 to December 2002. The mean follow-up period of the patients was 46 months (range: 3 to 92 months). AC depth was measured using an ultrasound biomicroscopy. Clinical data, including systemic disorders, intraocular pressure, and visual outcomes were recorded. The main outcome measures were AC depth in the diseased eye and the fellow eye of the same patient and the attack of ACG after CRVO.

Results

The mean AC depth in the diseased eyes was significantly shallower than in the unaffected fellow eyes (2.43 ± 0.45 mm vs. 2.55 ± 0.46 mm; p < 0.001). Four patients (17 %) developed ACG after the onset of CRVO within one month of the CRVO attack. In these four patients, the mean AC depth in the diseased eyes was 1.91 ± 0.21 mm, which was much shallower than the eyes without ACG attack (2.53 ± 0.40 mm).

Conclusions

AC depth is significantly shallower following the onset of CRVO. ACG can occur in patients after the onset of CRVO.
Literature
1.
Moisseiev J, Desatnik H, Cohen Y, Lusky A, Melamed S. Glaucoma and visual outcome in central retinal vein occlusion. Acta Ophthalmol Scand. 1996;74(4):368–71.CrossRefPubMed
2.
McIntosh RL, Rogers SL, Lim L, Cheung N, Wang JJ, Mitchell P, Kowalski JW, Nguyen HP, Wong TY. Natural history of central retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2010;117(6):1113–23. e1115.CrossRefPubMed
3.
Chan CK, Ip MS, Vanveldhuisen PC, Oden NL, Scott IU, Tolentino MJ, Blodi BA. SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion. Ophthalmology. 2011;118(7):1364–72.PubMedPubMedCentral
4.
Boyd SR, Zachary I, Chakravarthy U, Allen GJ, Wisdom GB, Cree IA, Martin JF, Hykin PG. Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. Arch Ophthalmol. 2002;120(12):1644–50.CrossRefPubMed
5.
Pe'er J, Folberg R, Itin A, Gnessin H, Hemo I, Keshet E. Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology. 1998;105(3):412–6.CrossRefPubMed
6.
Grant WM. Shallowing of the anterior chamber following occlusion of the central retinal vein. Am J Ophthalmol. 1973;75(3):384–7.CrossRefPubMed
7.
Bloome MA. Transient angle-closure glaucoma in central retinal vein occlusion. Ann Ophthalmol. 1977;9(1):44–8.PubMed
8.
Halikiopoulos D, Serle JB. Angle closure glaucoma secondary to hemiretinal vein occlusion. Br J Ophthalmol. 2001;85(11):1390.CrossRefPubMed
9.
10.
Michaelides M, Foster PJ. Retinal vein occlusion and angle closure: a retrospective case series. J Glaucoma. 2010;19(9):643–9.CrossRefPubMed
11.
Sonty S, Schwartz B. Vascular accidents in acute angle closure glaucoma. Ophthalmology. 1981;88(3):225–8.CrossRefPubMed
12.
Lin YW, Wang TH, Hung PT. Biometric study of acute primary angle-closure glaucoma. J Formos Med Assoc. 1997;96(11):908–12.PubMed
13.
Leung CK, Palmiero PM, Weinreb RN, Li H, Sbeity Z, Dorairaj S, Leung D, Liu S, Liebmann JM, Congdon N, et al. Comparisons of anterior segment biometry between Chinese and Caucasians using anterior segment optical coherence tomography. Br J Ophthalmol. 2010;94(9):1184–9.CrossRefPubMed
14.
Ramesh S, Maw C, Sutton CJ, Gandhewar JR, Kelly SP. Ethnic aspects of acute primary angle closure in a UK mulicultural conurbation. Eye (Lond). 2005;19(12):1271–5.CrossRef
15.
Aung T, Ang LP, Chan SP, Chew PT. Acute primary angle-closure: long-term intraocular pressure outcome in Asian eyes. Am J Ophthalmol. 2001;131(1):7–12.CrossRefPubMed
16.
Yip JL, Foster PJ. Ethnic differences in primary angle-closure glaucoma. Curr Opin Ophthalmol. 2006;17(2):175–80.CrossRefPubMed
17.
Wang D, Chiu C, He M, Wu L, Kao A, Lin S. Differences in baseline dark and the dark-to-light changes in anterior chamber angle parameters in whites and ethnic Chinese. Invest Ophthalmol Vis Sci. 2011;52(13):9404–10.CrossRefPubMedPubMedCentral
18.
Oh YG, Minelli S, Spaeth GL, Steinman WC. The anterior chamber angle is different in different racial groups: a gonioscopic study. Eye (Lond). 1994;8(Pt 1):104–8.CrossRef
19.
Risk factors for central retinal vein occlusion. The Eye Disease Case–control Study Group. Arch Ophthalmol. 1996, 114(5):545–554.
20.
Funderburk RL, Feinberg EB. Diabetes as a risk factor for retinal neovascularization in retinal vein occlusion. Ann Ophthalmol. 1989;21(2):65–6.PubMed
21.
Larsson J, Hillarp A, Olafsdottir E, Bauer B. Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion. Acta Ophthalmol Scand. 1999;77(6):634–7.CrossRefPubMed
22.
Narayanasamy A, Subramaniam B, Karunakaran C, Ranganathan P, Sivaramakrishnan R, Sharma T, Badrinath VS, Roy J. Hyperhomocysteinemia and low methionine stress are risk factors for central retinal venous occlusion in an Indian population. Invest Ophthalmol Vis Sci. 2007;48(4):1441–6.CrossRefPubMed
23.
Vine AK. Hyperhomocysteinemia: a risk factor for central retinal vein occlusion. Am J Ophthalmol. 2000;129(5):640–4.CrossRefPubMed
24.
Appiah AP, Trempe CL. Risk factors associated with branch vs. central retinal vein occlusion. Ann Ophthalmol. 1989;21(4):153–5. 157.PubMed
25.
Appiah AP, Trempe CL. Differences in contributory factors among hemicentral, central, and branch retinal vein occlusions. Ophthalmology. 1989;96(3):364–6.CrossRefPubMed
26.
Arend O, Remky A, Jung F, Kiesewetter H, Reim M, Wolf S. Role of rheologic factors in patients with acute central retinal vein occlusion. Ophthalmology. 1996;103(1):80–6.CrossRefPubMed
27.
Elman MJ, Bhatt AK, Quinlan PM, Enger C. The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion. Ophthalmology. 1990;97(11):1543–8.CrossRefPubMed
28.
Evans K, Wishart PK, McGalliard JN. Neovascular complications after central retinal vein occlusion. Eye (Lond). 1993;7(Pt 4):520–4.CrossRef
29.
Sperduto RD, Hiller R, Chew E, Seigel D, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Seddon JM, et al. Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case–control study. Ophthalmology. 1998;105(5):765–71.CrossRefPubMed
30.
Glacet-Bernard A, Chabanel A, Lelong F, Samama MM, Coscas G. Elevated erythrocyte aggregation in patients with central retinal vein occlusion and without conventional risk factors. Ophthalmology. 1994;101(9):1483–7.CrossRefPubMed
31.
Williamson TH, Baxter GM. Central retinal vein occlusion, an investigation by color Doppler imaging. Blood velocity characteristics and prediction of iris neovascularization. Ophthalmology. 1994;101(8):1362–72.CrossRefPubMed
32.
Luntz MH, Schenker HI. Retinal vascular accidents in glaucoma and ocular hypertension. Surv Ophthalmol. 1980;25(3):163–7.CrossRefPubMed
33.
34.
Metadata
Title
Anterior chamber depth and angle-closure glaucoma after central retinal vein occlusion
Authors
Shiu-Chen Wu
Yung-Sung Lee
Wei-Chi Wu
Shirley H. L. Chang
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2016
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-016-0256-7

Other articles of this Issue 1/2016

BMC Ophthalmology 1/2016 Go to the issue

Research article

Glaucoma awareness, knowledge, perception of risk and eye screening behaviour among residents of Abokobi, Ghana

Research article

Smartphone use is a risk factor for pediatric dry eye disease according to region and age: a case control study

Research article

Central corneal thickness in newly diagnosed glaucoma patients in South West Ethiopia: a cross-sectional study

Case report

Migration of rigid gas permeable contact lens into the upper eyelid after trauma: a case report

Research article

Effect of bradykinin on TGF-β1-induced retinal pigment epithelial cell proliferation and extracellular matrix secretion

Research article

Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term